ACLS Stock Recent News

BEVERLY, Mass. , Feb. 18, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fourteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 27 and 28, 2025.

Some investors worry about an expensive market near all-time highs. But not every stock is near its all-time high today, nor is every stock expensive.

Shares of Axcelis Technologies (ACLS -12.25%) sank in Tuesday's trading. The stock ended today's session down 12.3% and had been down as much as 14.6% earlier in the day.

Axcelis Technologies, Inc. (NASDAQ:ACLS ) Q4 2024 Earnings Call February 11, 2025 8:30 AM ET Company Participants David Ryzhik - SVP, IR and Corporate Strategy Russell Low - President and CEO James Coogan - EVP and CFO Conference Call Participants Charles Shi - Needham & Company Craig Ellis - B. Riley Securities Jed Dorsheimer - William Blair Jack Egan - Charter Equity Research David Duley - Steelhead Securities Thomas Diffely - D.A.

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $2.15 per share a year ago.

Q4 Highlights: Revenue of $252.4 million Operating Margin of 21.6% Diluted earnings per share of $1.54 BEVERLY, Mass. , Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2024.

Learn About the Latest Products and Upgrades that Accelerate Intelligent Solutions in Ion Implant BEVERLY, Mass. , Feb. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Purion™ platform of ion implanters at SEMICON Korea 2025.

In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $66.15, denoting a +0.68% change from the preceding trading day.

Award Recognizes Companies Who Achieve Highest Level of Safety BEVERLY, Mass. , Feb. 3, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, has received the '2024 SK hynix CSO Safety and Health Award'.

BEVERLY, Mass. , Jan. 23, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2024 after market close on Monday, February 10, 2025.